Edition:
United Kingdom

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.00USD
15 Dec 2017
Change (% chg)

$-0.10 (-3.23%)
Prev Close
$3.10
Open
$3.10
Day's High
$3.10
Day's Low
$3.00
Volume
119,914
Avg. Vol
50,109
52-wk High
$4.20
52-wk Low
$2.45

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Paul Cleveland

60 2017 Chairman of the Board

Amber Salzman

55 2017 Chief Executive Officer, Principal Executive Officer, Director

Leone Patterson

54 2016 Chief Financial Officer

Athena Countouriotis

45 2017 Senior Vice President, Chief Medical Officer

Mehdi Gasmi

50 2016 Chief Science and Technology Officer